GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Current Ratio

Nuformix (LSE:NFX) Current Ratio : 3.44 (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Nuformix's current ratio for the quarter that ended in Sep. 2022 was 3.44.

Nuformix has a current ratio of 3.44. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Nuformix's Current Ratio or its related term are showing as below:

LSE:NFX's Current Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.795
* Ranked among companies with meaningful Current Ratio only.

Nuformix Current Ratio Historical Data

The historical data trend for Nuformix's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Current Ratio Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Current Ratio
Get a 7-Day Free Trial 1.34 0.42 2.29 5.61 3.47

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.61 7.56 3.47 3.44 1.42

Competitive Comparison of Nuformix's Current Ratio

For the Biotechnology subindustry, Nuformix's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuformix's Current Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuformix's Current Ratio distribution charts can be found below:

* The bar in red indicates where Nuformix's Current Ratio falls into.



Nuformix Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Nuformix's Current Ratio for the fiscal year that ended in Mar. 2022 is calculated as

Current Ratio (A: Mar. 2022 )=Total Current Assets (A: Mar. 2022 )/Total Current Liabilities (A: Mar. 2022 )
=0.825/0.238
=3.47

Nuformix's Current Ratio for the quarter that ended in Sep. 2022 is calculated as

Current Ratio (Q: Sep. 2022 )=Total Current Assets (Q: Sep. 2022 )/Total Current Liabilities (Q: Sep. 2022 )
=0.647/0.188
=3.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuformix  (LSE:NFX) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Nuformix Current Ratio Related Terms

Thank you for viewing the detailed overview of Nuformix's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix (LSE:NFX) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix (LSE:NFX) Headlines

From GuruFocus

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 23,000 Shares

By GuruFocus Research GuruFocus Editor 03-11-2010

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 12-13-2010

Newfield Exploration Releases Second Quarter Report

By Black Iguana Nitish 09-30-2014

4 Independent Oil Drillers To Acquire Today

By Vatalyst.com Vatalyst.com 03-09-2012